Indication
Cutaneous candidiasis
Cutaneous candidiasis is a superficial fungal infection of the skin primarily caused by the opportunistic yeast *Candida albicans*, as well as other non-albicans *Candida* species. Read more about Cutaneous candidiasis
364 drugs 131 manufacturers
Drugs that treat it
Common Cutaneous candidiasis therapies.
ATHLETE'S FOOT SPRAY (miconazole nitrate)
CLOTRIMAZOLE
LOTRIMIN AF (miconazole nitrate)
LOTRIMIN AF (miconazole nitrate)
DESENEX (miconazole nitrate)
DESENEX (miconazole nitrate)
CICLOPIROX (ciclopirox olamine)
DESENEX (miconazole nitrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCutaneous candidiasis is a superficial fungal infection of the skin primarily caused by the opportunistic yeast *Candida albicans*, as well as other non-albicans *Candida* species.
It predominantly affects the integumentary system, flourishing in warm, moist, and occluded intertriginous areas such as the axillae, groin, inframammary folds, and digital web spaces.
Pathophysiologically driven by epidermal barrier compromise, local maceration, or altered host immunity, the condition clinically manifests as pruritic, bright red erythematous patches accompanied by maceration, peripheral scaling, and characteristic satellite pustules or papules.
- nih.gov
Cutaneous candidiasis is a superficial fungal infection of the skin primarily caused by the opportunistic yeast *Candida albicans*, as well as other non-albicans *Candida* species
- msdmanuals.com
Cutaneous candidiasis is a superficial fungal infection of the skin primarily caused by the opportunistic yeast *Candida albicans*, as well as other non-albicans *Candida* species It predominantly affects the integumentary system, flourishing in warm, moist, and occluded intertriginous areas such as the axillae, groin, inframammary folds, and digital web spaces Pathophysiologically driven by epidermal barrier compromise, local maceration, or altered host immunity, the condition clinically manife...
- wederm.com
Pathophysiologically driven by epidermal barrier compromise, local maceration, or altered host immunity, the condition clinically manifests as pruritic, bright red erythematous patches accompanied by maceration, peripheral scaling, and characteristic satellite pustules or papules
- nih.gov
Pathophysiologically driven by epidermal barrier compromise, local maceration, or altered host immunity, the condition clinically manifests as pruritic, bright red erythematous patches accompanied by maceration, peripheral scaling, and characteristic satellite pustules or papules
Personalize your experience
Follow Cutaneous candidiasis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.